MY ACCOUNT | NEWSLETTER |

Research traces development of anthrax resistance in humans


There are two key moments in the history of humanity and its resistance against anthrax. One was when humans adopted a more ruminant-based diet; another, when agricultural practices became entrenched. Now, a veterinary research group has studied how human resistance to this zoonotic disease has evolved over time.

For millennia, humans and anthrax have co-evolved. According to a study published in Nature Communications, this coexistence resulted in humans, particularly those of European descent, developing fewer anthrax receptors that allow the disease to develop.

"We found evidence of multiple stages of adaptation in humans, which is one of the most important aspects of our discovery," explains Charles Danko, a researcher at the Baker Institute for Animal Health at Cornell University and an author of the paper.

The main host of anthrax bacteria are ruminants, such as cattle and sheep. Grazing animals inhale the spores of the bacteria and become infected, and die from the toxins produced by the bacteria. The decomposing carcasses return the bacteria to the soil and vegetation, repeating the cycle.

However, it was not entirely clear how humans became implicated in the host-pathogen chain until Danko's team began to look at genetic patterns.

Genomic sequence analysis

Lauren Choate, currently a genomics fellow at the Mayo Clinic who collaborated with Danko's team, explored the genomic sequences of various species by examining existing human population databases and conducting experiments with human and non-human primate samples.

The observations found that gene expression of the anthrax toxin receptor 2 (ANTXR2), which allows the toxin access to host cells, was abundant throughout the family tree of mammals, including primates. However, this did not happen when it came to humans.

"The ANTXR2 gene is quite restricted in its expression level during 100 million years of evolution," says Danko. "But in humans we see that big decrease, and that's what we found so interesting."

It would be an evolutionary process: at the dawn of the appearance of humans in sub-Saharan Africa, hunter-gatherer cultures began to eat more ruminant meat and encountered anthrax more regularly than their primate ancestors. The disease would have wiped out many of these early humans, while those with a natural genetic resistance to anthrax, meaning fewer anthrax receptors, survived.

Different populations around the world

The research team also looked at the gene expressions of different human populations, including those of European, Chinese, Japanese, and Yoruba (a sub-Saharan African ethnic group) descent.

They found that while all showed a reduction in anthrax receptor expression compared to most mammals, the European group had an even greater reduction, and this means a lower risk of anthrax bacteria taking hold. This is consistent with observations that Europeans appear to be less sensitive to anthrax toxins than Africans or Asians.

"Our discovery shows that there is genetic evidence that Europeans have been living with anthrax for a longer period of time," says Danko, which would have allowed that population to develop natural immunity against the disease due to natural selection.

This is consistent with the path of human migration and agricultural practices. For example, England was long plagued by "wool sorter disease", caused by the inhalation of anthrax spores from infected wool by working-class wool sorters in the 19th century.

With this research, Danko's team has opened a door to how the molecular evolution of gene expression can lead to differences in disease resistance in the real world. The next steps in the investigation could go in several directions. "It would be interesting to see the impact of the spread of anthrax on other human populations that have historically been more isolated, and if that mimics the evolution we found in our study," says Choate.

Other avenues of investigation may involve finding the exact DNA sequences underlying expressed genes or looking for other host-pathogen co-evolutions.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Manoeuvring the innovative drug delivery systems for veterinary therapeutics: Present day demand

Like0
Dislike0

Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items

Like0
Dislike0

Management and medicine of backyard poultry

Like0
Dislike0

Horse makes immediate recovery following removal of large nasal mass

Like0
Dislike0

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top